The FDA’s draft guidance aims to improve diversity in clinical trials by encouraging manufacturers to set enrolment goals based on age, ethnicity, sex, and race.
FDA unveils plan to boost diversity in clinical trials
Original Article by Manas Mishra & Bhanvi Satija | Reuters | 26 June 2024
The FDA's draft guidance aims to improve diversity in clinical trials by encouraging manufacturers to set enrolment goals based on age, ethnicity, sex, and race.
More Posts
Thembisile Xulu Named New Health Director-General
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
Read more...
Gauteng Nurse Shortage Deepens, Threatening NHI Rollout
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
Read more...
Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Read more...